Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dick

Showing results (411-420 of 415) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 415 results.
Nature Medicine|January 16, 2018
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatmentMarc L Hyer, Michael A Milhollen, Jeff Ciavarri, et al.
Nature|April 11, 2009
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancerTeresa A Soucy, Peter G Smith, Michael A Milhollen, et al.
Science (New York, N.Y.)|June 2, 2022
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategyStanley C Xie, Riley D Metcalfe, Elyse Dunn, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2021
Design of proteasome inhibitors with oral efficacy in vivo against <i>Plasmodium falciparum</i> and selectivity over the human proteasomeStanley C Xie, Riley D Metcalfe, Hirotake Mizutani, et al.
Plos Pathogens|December 9, 2024
A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivoStanley C Xie, Chia-Wei Tai, Craig J Morton, et al.
Pageof 42

Showing results (411-420 of 415) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 415 results.
Nature Medicine|January 16, 2018
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatmentMarc L Hyer, Michael A Milhollen, Jeff Ciavarri, et al.
Nature|April 11, 2009
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancerTeresa A Soucy, Peter G Smith, Michael A Milhollen, et al.
Science (New York, N.Y.)|June 2, 2022
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategyStanley C Xie, Riley D Metcalfe, Elyse Dunn, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2021
Design of proteasome inhibitors with oral efficacy in vivo against <i>Plasmodium falciparum</i> and selectivity over the human proteasomeStanley C Xie, Riley D Metcalfe, Hirotake Mizutani, et al.
Plos Pathogens|December 9, 2024
A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivoStanley C Xie, Chia-Wei Tai, Craig J Morton, et al.
Pageof 42